JENNIFER MORRIS: Open Payments
NPI 1760949184 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,404 in 157 payments from 22 companies in 2025. Trend: 2023 $1,622 · 2024 $2,721 · 2025 $2,404
Food & beverage: $2,404
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 48 | $566 |
| ABBVIE INC. | 32 | $353 |
| AstraZeneca Pharmaceuticals LP | 10 | $248 |
| GlaxoSmithKline, LLC. | 11 | $197 |
| Novo Nordisk Inc | 11 | $180 |
| Lilly USA, LLC | 11 | $147 |
| Teva Pharmaceuticals USA, Inc. | 4 | $114 |
| Vanda Pharmaceuticals Inc. | 4 | $101 |
| Phathom Pharmaceuticals, Inc. | 6 | $79 |
| Insulet Corporation | 3 | $54 |
Products named: NURTEC ODT, FARXIGA, TRELEGY ELLIPTA, QULIPTA, AUSTEDO XR, VRAYLAR, FANAPT, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
